The smart way to treat myopia in children.

MiYOSMART

An estimated 5 billion people, or half the global population, could be affected by myopia by 2050.

Myopia is a global concern.

Annual myopia progression rate is most rapid under 10 years of age. Significantly greater rates of progression can be seen especially in children with high myopia.

If left untreated, myopia can lead to lasting vision problems, but together we can curb myopia in children.

An innovative spectacle lens.

This spectacle lens is based on revolutionary Defocus Incorporated Multiple Segments (D.I.M.S.) Technology. This was developed in collaboration with The Hong Kong Polytechnic University in 2014. MiYOSMART spectacle lenses are easy to fit and look just like a regular single vision lens.

 

In 2018, MiYOSMART spectacle lenses won the Gold Prize, Grand Award & Special Gold Award International Exhibition of Inventions of Geneva, Switzerland. In 2020, they also won the Silmo d’Or Award in the Vision category at the Silmo Paris Optical Fair.

A revolutionary technology.

With the exclusive non-invasive D.I.M.S. Technology, the lens provides a full vision correction and has a ring shaped treatment zone to slow down myopia progression. The combination of the focus zone and treatment zone provides clear vision and manages myopia simultaneously.

Published scientific studies in the British Journal of Ophthalmology:

Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomized clinical trial. (Published 11 Dec. 2019)

read article

Myopia control effect of Defocus Incorporated Multiple Segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study. (Published Online First: 17 March 2021)

read article

Designed to suit a child’s active life.

MiYOSMART spectacle lenses have an easy-to-clean specific anti-reflective, durable coating. With MiYOSMART's Eye Shield, young patients get the added assurance of an impact resistant material and UV protection.

1 Brien Holden Vision Institute; 2 Shanghai Eye Disease Prevention and Treatment Center https://guidelines.brienholdenvision.org, accessed 16.08.1018.

2 Lam CSY, Tang WC, Lee RPK, Chun RKM, To CH. A randomized clinical trial for myopia control – use of myopic defocus spectacle lens. 8th International Congress of Behavioral Optometry (ICBO), 26- 29 of April 2018. Sydney, Australia. 8Sankaridurg P1, Tilia D1, Morton M1, Weng R1, Jong M1, Zhu F2. Guidelines for Myopia Management.